Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Breast Cancer
Title
DCIS, HER2 Positive
Description
A phase III clinical trial comparing Trastuzumab given concurrently with Radiation Therapy and Radiation Therapy alone for women with Her2-Positive Ductal Carcinoma In Situ resected by Lumpectomy
Breast Cancer - B-43
IRB Number
NCT00769379
Inclusion/Notes

For more information, please click here: http://www.clinicaltrials.gov/ct2/show/NCT00769379?term=NCT00769379&rank=1

Status
Open to Enrollment
Principal Investigator
Frederic C. Kass, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117
Alternate Phone
(805) 879-0643

This is the fat footer - edit page 906 to add content.